Matches in SemOpenAlex for { <https://semopenalex.org/work/W2802042505> ?p ?o ?g. }
- W2802042505 abstract "Background Treatment-induced neuroendocrine prostate cancer (tNEPC) is an aggressive variant of late-stage metastatic castrate-resistant prostate cancer that commonly arises through neuroendocrine transdifferentiation (NEtD). Treatment options are limited, ineffective, and, for most patients, result in death in less than a year. We previously developed a first-in-field patient-derived xenograft (PDX) model of NEtD. Longitudinal deep transcriptome profiling of this model enabled monitoring of dynamic transcriptional changes during NEtD and in the context of androgen deprivation. Long non-coding RNA (lncRNA) are implicated in cancer where they can control gene regulation. Until now, the expression of lncRNAs during NEtD and their clinical associations were unexplored. Results We implemented a next-generation sequence analysis pipeline that can detect transcripts at low expression levels and built a genome-wide catalogue (n = 37,749) of lncRNAs. We applied this pipeline to 927 clinical samples and our high-fidelity NEtD model LTL331 and identified 821 lncRNAs in NEPC. Among these are 122 lncRNAs that robustly distinguish NEPC from prostate adenocarcinoma (AD) patient tumours. The highest expressed lncRNAs within this signature are H19, LINC00617, and SSTR5-AS1. Another 742 are associated with the NEtD process and fall into four distinct patterns of expression (NEtD lncRNA Class I, II, III, and IV) in our PDX model and clinical samples. Each class has significant (z-scores >2) and unique enrichment for transcription factor binding site (TFBS) motifs in their sequences. Enriched TFBS include (1) TP53 and BRN1 in Class I, (2) ELF5, SPIC, and HOXD1 in Class II, (3) SPDEF in Class III, (4) HSF1 and FOXA1 in Class IV, and (5) TWIST1 when merging Class III with IV. Common TFBS in all NEtD lncRNA were also identified and include E2F, REST, PAX5, PAX9, and STAF. Interrogation of the top deregulated candidates (n = 100) in radical prostatectomy adenocarcinoma samples with long-term follow-up (median 18 years) revealed significant clinicopathological associations. Specifically, we identified 25 that are associated with rapid metastasis following androgen deprivation therapy (ADT). Two of these lncRNAs (SSTR5-AS1 and LINC00514) stratified patients undergoing ADT based on patient outcome. Discussion To date, a comprehensive characterization of the dynamic landscape of lncRNAs during the NEtD process has not been performed. A temporal analysis of the PDX-based NEtD model has for the first time provided this dynamic landscape. TFBS analysis identified NEPC-related TF motifs present within the NEtD lncRNA sequences, suggesting functional roles for these lncRNAs in NEPC pathogenesis. Furthermore, select NEtD lncRNAs appear to be associated with metastasis and patients receiving ADT. Treatment-related metastasis is a clinical consequence of NEPC tumours. Top candidate lncRNAs FENDRR, H19, LINC00514, LINC00617, and SSTR5-AS1 identified in this study are implicated in the development of NEPC. We present here for the first time a genome-wide catalogue of NEtD lncRNAs that characterize the transdifferentiation process and a robust NEPC lncRNA patient expression signature. To accomplish this, we carried out the largest integrative study that applied a PDX NEtD model to clinical samples. These NEtD and NEPC lncRNAs are strong candidates for clinical biomarkers and therapeutic targets and warrant further investigation." @default.
- W2802042505 created "2018-05-17" @default.
- W2802042505 creator A5000506061 @default.
- W2802042505 creator A5008552473 @default.
- W2802042505 creator A5014582211 @default.
- W2802042505 creator A5019770974 @default.
- W2802042505 creator A5022171084 @default.
- W2802042505 creator A5028809573 @default.
- W2802042505 creator A5030221990 @default.
- W2802042505 creator A5031262888 @default.
- W2802042505 creator A5032201078 @default.
- W2802042505 creator A5032349610 @default.
- W2802042505 creator A5035068594 @default.
- W2802042505 creator A5044704274 @default.
- W2802042505 creator A5047882814 @default.
- W2802042505 creator A5050325886 @default.
- W2802042505 creator A5055207707 @default.
- W2802042505 creator A5057827979 @default.
- W2802042505 creator A5062125605 @default.
- W2802042505 creator A5065248141 @default.
- W2802042505 creator A5074031951 @default.
- W2802042505 creator A5078888279 @default.
- W2802042505 creator A5081085894 @default.
- W2802042505 creator A5081653545 @default.
- W2802042505 creator A5083427841 @default.
- W2802042505 creator A5084563414 @default.
- W2802042505 creator A5088764468 @default.
- W2802042505 date "2018-05-10" @default.
- W2802042505 modified "2023-10-17" @default.
- W2802042505 title "The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications" @default.
- W2802042505 cites W1519912424 @default.
- W2802042505 cites W1585370022 @default.
- W2802042505 cites W1837389858 @default.
- W2802042505 cites W1859579038 @default.
- W2802042505 cites W1859714693 @default.
- W2802042505 cites W1861026401 @default.
- W2802042505 cites W1897003648 @default.
- W2802042505 cites W1923726874 @default.
- W2802042505 cites W1949146490 @default.
- W2802042505 cites W1963740134 @default.
- W2802042505 cites W1966517158 @default.
- W2802042505 cites W1967910782 @default.
- W2802042505 cites W1969185046 @default.
- W2802042505 cites W1972248262 @default.
- W2802042505 cites W1972298018 @default.
- W2802042505 cites W1972383646 @default.
- W2802042505 cites W1975356306 @default.
- W2802042505 cites W1976149758 @default.
- W2802042505 cites W1977951592 @default.
- W2802042505 cites W1981361342 @default.
- W2802042505 cites W1982124759 @default.
- W2802042505 cites W1986022087 @default.
- W2802042505 cites W1997423100 @default.
- W2802042505 cites W1997762751 @default.
- W2802042505 cites W1998343146 @default.
- W2802042505 cites W1999687329 @default.
- W2802042505 cites W2001730700 @default.
- W2802042505 cites W2001994418 @default.
- W2802042505 cites W2004945910 @default.
- W2802042505 cites W2006027491 @default.
- W2802042505 cites W2008695914 @default.
- W2802042505 cites W2009109655 @default.
- W2802042505 cites W2011714693 @default.
- W2802042505 cites W2014366669 @default.
- W2802042505 cites W2023400202 @default.
- W2802042505 cites W2027881996 @default.
- W2802042505 cites W2028780089 @default.
- W2802042505 cites W2029919331 @default.
- W2802042505 cites W2035730185 @default.
- W2802042505 cites W2036008499 @default.
- W2802042505 cites W2039408641 @default.
- W2802042505 cites W2039511031 @default.
- W2802042505 cites W2041034966 @default.
- W2802042505 cites W2049541774 @default.
- W2802042505 cites W2051025382 @default.
- W2802042505 cites W2051216358 @default.
- W2802042505 cites W2051303456 @default.
- W2802042505 cites W2052741109 @default.
- W2802042505 cites W2052858101 @default.
- W2802042505 cites W2059191987 @default.
- W2802042505 cites W2061178402 @default.
- W2802042505 cites W2063116472 @default.
- W2802042505 cites W2064539600 @default.
- W2802042505 cites W2064879068 @default.
- W2802042505 cites W2068728873 @default.
- W2802042505 cites W2074613286 @default.
- W2802042505 cites W2079957854 @default.
- W2802042505 cites W2080609358 @default.
- W2802042505 cites W2084639301 @default.
- W2802042505 cites W2085005232 @default.
- W2802042505 cites W2088125732 @default.
- W2802042505 cites W2089050448 @default.
- W2802042505 cites W2091151146 @default.
- W2802042505 cites W2092826435 @default.
- W2802042505 cites W2094581962 @default.
- W2802042505 cites W2097121410 @default.
- W2802042505 cites W2100305481 @default.
- W2802042505 cites W2100441605 @default.
- W2802042505 cites W2103339837 @default.
- W2802042505 cites W2103848900 @default.